Y-Biologics, Inc. (KOSDAQ:338840)

South Korea · Delayed Price · Currency is KRW

9,330.00

0.00 (0.00%)

At close: Jul 27, 2026

Y-Biologics Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,788	2,913	5,763	3,479	4,151	4,847
Revenue Growth	-44.55%	-49.45%	65.64%	-16.18%	-14.37%	-27.99%
Gross Profit	2,189	2,294	4,267	2,338	1,255	2,319
Operating Income	-10,891	-9,269	-8,447	-10,143	-18,830	-17,365
Net Income	-44,461	-42,025	-6,442	-20,871	-18,804	-17,071
Earnings Per Share	-2967.27	-2821.86	-436.00	-1667.00	-1530.00	-1403.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	41,169	44,269	12,204	20,898	12,983	16,948
Total Debt	15,628	14,753	778.76	2,892	4,940	5,955
Net Cash (Debt)	25,541	29,516	11,425	18,005	8,043	10,992
Net Cash Growth	164.82%	158.35%	-36.55%	123.86%	-26.83%	-60.80%
Net Cash Per Share	1704.59	1981.91	773.28	1438.09	654.40	903.42

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-6,510	-5,840	-4,143	-7,607	-10,105	-9,168
Capital Expenditures	-1,528	-1,025	-2,860	-193.42	-1,088	-7,552
Free Cash Flow	-8,038	-6,865	-7,003	-7,801	-11,193	-16,720
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	78.53%	78.75%	74.05%	67.21%	30.25%	47.85%
Operating Margin	-390.67%	-318.20%	-146.58%	-291.53%	-453.68%	-358.23%
Pretax Margin	-1594.90%	-1442.67%	-111.78%	-599.90%	-453.06%	-352.17%
Profit Margin	-1594.90%	-1442.67%	-111.78%	-599.90%	-453.06%	-352.17%
FCF Margin	-288.34%	-235.66%	-121.52%	-224.21%	-269.68%	-344.94%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	47.52	119.32	19.73	66.19	-	-